Patents by Inventor Jakob Dogan

Jakob Dogan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions, methods and uses
    Patent number: 10118949
    Abstract: The present invention relates to a class of engineered polypeptides having a binding affinity for albumin. It also relates to new methods and uses that exploit binding by these and other compounds to albumin in different contexts, some of which have significance for the treatment of disease in mammals including humans.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: November 6, 2018
    Assignee: AFFIBODY AB
    Inventors: Lars Abrahmsén, Andreas Jonsson, Jakob Dogan, Per-Åke Nygren
  • COMPOSITIONS, METHODS AND USES
    Publication number: 20150158916
    Abstract: The present invention relates to a class of engineered polypeptides having a binding affinity for albumin. It also relates to new methods and uses that exploit binding by these and other compounds to albumin in different contexts, some of which have significance for the treatment of disease in mammals including humans.
    Type: Application
    Filed: November 24, 2014
    Publication date: June 11, 2015
    Inventors: Lars Abrahmsén, Andreas Jonsson, Jakob Dogan, Per-Åke Nygren
  • Compositions, methods and uses
    Patent number: 8937153
    Abstract: The present invention relates to a class of engineered polypeptides having a binding affinity for albumin. It also relates to new methods and uses that exploit binding by these and other compounds to albumin in different contexts, some of which have significance for the treatment of disease in mammals including humans.
    Type: Grant
    Filed: July 17, 2008
    Date of Patent: January 20, 2015
    Assignee: Affibody AB
    Inventors: Lars Abrahmsén, Andreas Jonsson, Jakob Dogan, Per-Åke Nygren
  • COMPOSITIONS, METHODS AND USES
    Publication number: 20100273979
    Abstract: The present invention relates to a class of engineered polypeptides having a binding affinity for albumin. It also relates to new methods and uses that exploit binding by these and other compounds to albumin in different contexts, some of which have significance for the treatment of disease in mammals including humans.
    Type: Application
    Filed: July 17, 2008
    Publication date: October 28, 2010
    Inventors: Lars Abrahmsén, Andreas Jonsson, Jakob Dogan, Per-Åke Nygren